Quick Guide to Recent Changes We’ve Made to G2’s Reports
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
A new name comes with Lab Industry Advisor, but the goal of helping labs remains the same.
The rules unfairly favor insurers in out-of-network payment disputes, court says.
Though not yet recommended for screening by the ACS or other medical groups, recently developed blood-based tests show promise.
Recently announced enforcement actions saw three big settlements, with two of those coming from medical centers.
Labs may be billing Medicare for high-reimbursing and medically unnecessary drug tests, according to the OIG.
Though the e-commerce giant recently closed its acquisition of One Medical, FTC antitrust intervention could disrupt Amazon’s plans.
Though labs were again absent from recent key enforcement actions, sentences were handed down in other healthcare-related cases.
Drying COVID-19 testing demand drove revenues down, but not as much as expected.
Not disclosing list prices of uncovered lab tests on ABN is not consumer fraud, court says.
Though last week’s cases didn’t involve labs or lab testing, most were FCA-related issues including inflated claims.
Specially crafted lab tests speed up adoption of novel drug treatments.